Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
FAQs about Oncology Learning Network:How many episodes does Oncology Learning Network have?The podcast currently has 185 episodes available.
February 20, 2019Great Debates in Oncology: Preview of Round 1 - Dr TrentGreat Debates in Oncology: Preview of Round 1 - Dr Trent by HMP Global...more2minPlay
February 19, 2019Practice-Changing Potential in CLLPractice-Changing Potential in CLL by HMP Global...more3minPlay
February 14, 2019Apalutamide Significantly Delays Metastasis in SPARTAN Trial of Nonmetastatic CRPCApalutamide Significantly Delays Metastasis in SPARTAN Trial of Nonmetastatic CRPC by HMP Global...more9minPlay
February 14, 2019New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCCNew Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC by HMP Global...more10minPlay
January 30, 2019Round 3: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue SarcomaRound 3: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global...more13minPlay
January 23, 2019Round 2: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue SarcomaRound 2: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global...more23minPlay
January 22, 2019CLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World RegistryCLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World Registry by HMP Global...more3minPlay
December 21, 2018Gemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AMLGemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AML by HMP Global...more9minPlay
December 20, 2018Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AMLEarly Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML by HMP Global...more7minPlay
December 20, 2018Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AMLExtended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML by HMP Global...more5minPlay
FAQs about Oncology Learning Network:How many episodes does Oncology Learning Network have?The podcast currently has 185 episodes available.